Join
Live feed
·
PRReleasevia Quantisnow
IN8bio Inc. logo

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

ByQuantisnow·Wall Street's wire, on your screen.
INAB· IN8bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INAB (IN8bio Inc.) and more on Quantisnow.